1973 related articles for article (PubMed ID: 31228940)
21. RNA methylation-mediated LINC01559 suppresses colorectal cancer progression by regulating the miR-106b-5p/PTEN axis.
Shi K; Yang S; Chen C; Shao B; Guo Y; Wu X; Zhao L; Yang X; Zhang Q; Yuan W; Sun Z
Int J Biol Sci; 2022; 18(7):3048-3065. PubMed ID: 35541914
[TBL] [Abstract][Full Text] [Related]
22. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
[TBL] [Abstract][Full Text] [Related]
23. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
[TBL] [Abstract][Full Text] [Related]
24. METTL3/YTHDF2 m
Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
[TBL] [Abstract][Full Text] [Related]
25. m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.
Xu J; Chen Q; Tian K; Liang R; Chen T; Gong A; Mathy NW; Yu T; Chen X
Oncol Rep; 2020 Sep; 44(3):973-986. PubMed ID: 32705223
[TBL] [Abstract][Full Text] [Related]
26. USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer.
Man X; Piao C; Lin X; Kong C; Cui X; Jiang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):259. PubMed ID: 31200745
[TBL] [Abstract][Full Text] [Related]
27. Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
Qian K; Xu W; Xia X; Ding J
Genes Genomics; 2022 Dec; 44(12):1519-1530. PubMed ID: 36040683
[TBL] [Abstract][Full Text] [Related]
28. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
Ye K; Li L; Wu B; Wang D
Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
[TBL] [Abstract][Full Text] [Related]
29. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.
Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395
[TBL] [Abstract][Full Text] [Related]
30. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970
[TBL] [Abstract][Full Text] [Related]
31. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
32. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination.
Shen C; Liu J; Xie F; Yu Y; Ma X; Hu D; Liu C; Wang Y
Cancer Lett; 2024 Jul; 595():217002. PubMed ID: 38823761
[TBL] [Abstract][Full Text] [Related]
33. N
Jin H; Ying X; Que B; Wang X; Chao Y; Zhang H; Yuan Z; Qi D; Lin S; Min W; Yang M; Ji W
EBioMedicine; 2019 Sep; 47():195-207. PubMed ID: 31409574
[TBL] [Abstract][Full Text] [Related]
34. Cancer-associated fibroblasts-derived exosomal METTL3 promotes the proliferation, invasion, stemness and glutaminolysis in non-small cell lung cancer cells by eliciting SLC7A5 m6A modification.
Fan Y; Yu Y
Hum Cell; 2024 Jul; 37(4):1120-1131. PubMed ID: 38625505
[TBL] [Abstract][Full Text] [Related]
35. METTL3 promotes non-small-cell lung cancer growth and metastasis by inhibiting FDX1 through copper death-associated pri-miR-21-5p maturation.
Qian S; Liu J; Liao W; Wang F
Epigenomics; 2023 Dec; 15(23):1237-1255. PubMed ID: 38126112
[TBL] [Abstract][Full Text] [Related]
36. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
Dou X; Wang Z; Lu W; Miao L; Zhao Y
BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
[TBL] [Abstract][Full Text] [Related]
37. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma.
Guo S; Chen F; Li L; Dou S; Li Q; Huang Y; Li Z; Liu W; Zhang G
J Adv Res; 2024 Jul; 61():165-178. PubMed ID: 37619934
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN.
Lu Q; Liu T; Feng H; Yang R; Zhao X; Chen W; Jiang B; Qin H; Guo X; Liu M; Li L; Guo H
Mol Cancer; 2019 Jun; 18(1):111. PubMed ID: 31228937
[TBL] [Abstract][Full Text] [Related]
39. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
Yi J; Peng F; Zhao J; Gong X
Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
[TBL] [Abstract][Full Text] [Related]
40. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner.
Zhu W; Si Y; Xu J; Lin Y; Wang JZ; Cao M; Sun S; Ding Q; Zhu L; Wei JF
J Cell Mol Med; 2020 Mar; 24(6):3521-3533. PubMed ID: 32039568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
